全文获取类型
收费全文 | 13938篇 |
免费 | 1020篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 69篇 |
儿科学 | 550篇 |
妇产科学 | 482篇 |
基础医学 | 1713篇 |
口腔科学 | 149篇 |
临床医学 | 2245篇 |
内科学 | 2308篇 |
皮肤病学 | 185篇 |
神经病学 | 1294篇 |
特种医学 | 268篇 |
外科学 | 1179篇 |
综合类 | 306篇 |
一般理论 | 25篇 |
预防医学 | 2274篇 |
眼科学 | 188篇 |
药学 | 944篇 |
1篇 | |
中国医学 | 23篇 |
肿瘤学 | 777篇 |
出版年
2023年 | 150篇 |
2022年 | 205篇 |
2021年 | 382篇 |
2020年 | 255篇 |
2019年 | 402篇 |
2018年 | 459篇 |
2017年 | 283篇 |
2016年 | 375篇 |
2015年 | 387篇 |
2014年 | 532篇 |
2013年 | 711篇 |
2012年 | 1170篇 |
2011年 | 1187篇 |
2010年 | 565篇 |
2009年 | 500篇 |
2008年 | 938篇 |
2007年 | 1011篇 |
2006年 | 938篇 |
2005年 | 869篇 |
2004年 | 841篇 |
2003年 | 751篇 |
2002年 | 671篇 |
2001年 | 137篇 |
2000年 | 80篇 |
1999年 | 121篇 |
1998年 | 122篇 |
1997年 | 81篇 |
1996年 | 73篇 |
1995年 | 71篇 |
1994年 | 69篇 |
1993年 | 67篇 |
1992年 | 61篇 |
1991年 | 42篇 |
1990年 | 28篇 |
1989年 | 28篇 |
1988年 | 30篇 |
1987年 | 38篇 |
1986年 | 45篇 |
1985年 | 24篇 |
1984年 | 12篇 |
1983年 | 22篇 |
1982年 | 21篇 |
1981年 | 29篇 |
1980年 | 13篇 |
1979年 | 25篇 |
1978年 | 13篇 |
1973年 | 15篇 |
1972年 | 13篇 |
1970年 | 11篇 |
1969年 | 10篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
Brenda Faiola Alison K Bauer Elizabeth S Fuller Victoria A Wong Linda J Pluta Diane J Abernethy James B Mangum Jeffrey I Everitt Leslie Recio 《Toxicological sciences》2003,75(2):321-332
Benzene, a carcinogen that induces chromosomal breaks, is strongly associated with leukemias in humans. Possible genetic determinants of benzene susceptibility include proteins involved in repair of benzene-induced DNA damage. The catalytic subunit of DNA-dependent protein kinase (DNA-PKcs), encoded by Prkdc, is one such protein. DNA-PKcs is involved in the nonhomologous end-joining (NHEJ) pathway of DNA double-strand break (DSB) repair. Here we compared the toxic effects of benzene on mice (C57BL/6 and 129/Sv) homozygous for the wild-type Prkdc allele and mice (129/SvJ) homozygous for a Prkdc functional polymorphism that leads to diminished DNA-PK activity and enhanced apoptosis in response to radiation-induced damage. Male and female mice were exposed to 0, 10, 50, or 100 ppm benzene for 6 h/d, 5 d/week for 2 weeks. Male mice were more susceptible to benzene toxicity compared with females. Hematotoxicity was evident in all male mice but was not seen in female mice. We observed similar, large increases in both micronucleated erythrocyte populations in all male mice. Female mice had smaller but significant increases in micronucleated cells. The p53-dependent response was induced in all strains and genders of mice following benzene exposure, as indicated by an increase in p21 mRNA levels in bone marrow that frequently corresponded with cell cycle arrest in G2/M. Prkdc does not appear to be a significant genetic susceptibility factor for acute benzene toxicity. Moreover, the role of NHEJ, mediated by DNA-PK, in restoring genomic integrity following benzene-induced DSB remains equivocal. 相似文献
92.
Beatrice M Seddon Geoffrey S Payne Laura Simmons Ruth Ruddle Rachel Grimshaw Siew Tan Alison Turner Florence Raynaud Gavin Halbert Martin O Leach Ian Judson Paul Workman 《Clinical cancer research》2003,9(14):5101-5112
PURPOSE: To perform a Phase I study of SR-4554, a fluorinated 2-nitroimidazole noninvasive probe of tumor hypoxia detected by (19)F magnetic resonance spectroscopy (MRS). EXPERIMENTAL DESIGN: SR-4554 administration, on days 1 and 8, was followed by plasma sampling for pharmacokinetic studies and by three MRS studies performed over 24 h on days 8 and 9. Unlocalized MR spectra were acquired from tumor (10- or 16-cm dual resonant 1H/19F surface coil; 1.5 T Siemens Vision MR system; 2048 transients acquired over 34 min; 1.28-ms adiabatic pulse; repetition time, 1 s). Plasma drug concentrations were measured with a validated high-performance liquid chromatography method. Noncompartmental pharmacokinetic analysis was performed. RESULTS: Eight patients underwent pharmacokinetic studies, receiving doses of SR-4554 of 400-1600 mg/m(2). Peak plasma concentrations increased linearly with the SR-4554 dose (r(2) = 0.80; P = 0.0002). The plasma elimination half-life was relatively short (mean +/- SD, 3.28 +/- 0.59 h), and plasma clearance was quite rapid (mean +/- SD, 12.8 +/- 3.3 liters/h). Urinary recovery was generally high. SR-4554 was well tolerated. A single patient experienced dose-limiting toxicity (nausea and vomiting) at 1600 mg/m(2). The maximum tolerated dose was 1400 mg/m(2). SR-4554 was detected spectroscopically in tumors immediately after infusion at doses of 400-1600 mg/m(2). At the highest dose (1600 mg/m(2)), SR-4554 was detectable in tumor at 8 h, but not at 27 h. CONCLUSIONS: SR-4554 has plasma pharmacokinetic and toxicity profiles suitable for use as a hypoxia probe. It can be detected in tumors by unlocalized MRS. Additional clinical studies are warranted. 相似文献
93.
Chandradhar Dwivedi Xiangming Guan Wendy L Harmsen Alison L Voss Dawn E Goetz-Parten Erin M Koopman Kelly M Johnson Hima B Valluri Duane P Matthees 《Cancer epidemiology, biomarkers & prevention》2003,12(2):151-156
Studies from our laboratory have indicated skin cancer chemopreventive effectsof sandalwood oil in CD-1 mice. The purpose of this investigation was to study the skin cancer chemopreventive effects of alpha-santalol, a principal component of sandalwood oil in CD-1 and SENCAR mice. alpha-Santalol was isolated from sandalwood oil by distillation under vacuum and characterized by nuclear magnetic resonance and gas chromatography-mass spectrometry. Chemopreventive effects of alpha-santalol were determined during initiation and promotion phase in female CD-1 and SENCAR mice. Carcinogenesis was initiated with 7,12-dimethylbenz(a)anthracene and promoted with 12-O-tetradecanoylphorbol-13-acetate (TPA). The effects of alpha-santalol treatment on TPA-induced epidermal ornithine decarboxylase (ODC) activity and (3)H-thymidine incorporation in epidermal DNA of CD-1 and SENCAR mice were also investigated. alpha-Santalol treatment during promotion phase delayed the papilloma development by 2 weeks in both CD-1 and SENCAR strains of mice. alpha-Santalol treatment during promotion phase significantly (P < 0.05) decreased the papilloma incidence and multiplicity when compared with control and treatment during initiation phase during 20 weeks of promotion in both CD-1 and SENCAR strains of mice. alpha-Santalol treatment resulted in a significant (P < 0.05) inhibition in TPA-induced ODC activity and incorporation of (3)H-thymidine in DNA in the epidermis of both strains of mice. alpha-Santalol significantly prevents papilloma development during promotion phase of 7,12-dimethylbenz(a)anthracene-TPA carcinogenesis protocol in both CD-1 and SENCAR mice, possibly by inhibiting TPA-induced ODC activity and DNA synthesis. alpha-Santalol could be an effective chemopreventive agent for skin cancer. Additional experimental and clinical studies are needed to investigate the chemopreventive effect of alpha-santalol in skin cancer. 相似文献
94.
95.
96.
Keflemariam Yohannes Paul Roche Charlie Blumer Jenean Spencer Alison Milton Chris Bunn Heather Gidding Martyn Kirk Tony Della-Porta 《Communicable diseases intelligence》2004,28(1):6-68
There were 57 infectious diseases notifiable at the national level in Australia in 2002. States and territories reported 100,278 cases of infectious diseases to the National Notifiable Diseases Surveillance System (NNDSS), a fall of 4 per cent compared to the number of notifications in 2001. In 2002, the most frequently notified diseases were, sexually transmitted infections (31,929 reports, 32% of total notifications), gastrointestinal infections (26,708 reports, 27% of total notifications) and bloodborne infections (23,741, 24%). There were 11,711 (12% of total) cases of vaccine preventable diseases, 3,052 (3% of total) cases of vectorborne diseases, 1,155 (1% of total) cases of zoonotic infections, two cases of quarantinable diseases (Vibrio cholerae O1) and 1,980 cases of other bacterial diseases, notified to NNDSS. Compared to 2001, notifications of sexually transmitted infections increased by 16 per cent and gastrointestinal infections by 2 per cent while bloodborne infections fell by 18 per cent. The number of notifications of chlamydial infection and Q fever were the highest since 1991 and 1995 respectively. By contrast, the number of notification for hepatitis A and measles were the lowest since 1991. For other notifiable diseases, the number of notifications was within the range of the five years between 1997 and 2002 (range = five-year mean plus or minus two standard deviations). This report also includes 2002 summary data on communicable diseases from other surveillance systems including the Laboratory Virology and Serology Reporting Scheme and sentinel general practitioner schemes. 相似文献
97.
98.
99.
100.